← Leaderboards
Juan Troncoso
Johns Hopkins University
$17,207,387
Attributed
$25,237,473
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,237,473 · 20
By mechanism
P50$8,938,721 · 10
U01$8,400,098 · 1
P30$3,228,791 · 3
U19$1,912,967 · 2
R01$1,545,007 · 1
R21$449,907 · 1
Top collaborators
- David A Bennett9 shared
- Daniel H Geschwind9 shared
- Allan I Levey9 shared
- Thomas J Montine9 shared
- John Q. Trojanowski9 shared
- Dan E Arking2 shared
- Rozenn Lemaitre2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Rebecca F Gottesman$18,319,927
- William M Baldwin$16,703,281
- Richard Holubkov$11,946,832
- Amanda Nickles Fader$1,935,907
- Nabil J. Alkayed$25,658,018
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseAutopsyResearch PersonnelNeuropathologyBrainDiagnosisDementiaCohortTissuesParticipantNeurodegenerative DisordersBrain TissuePathogenesisDatabasesResourcesAgingPathologySpecimenBiological MarkersTrainingEnrollmentClinicBase
Grant awards (88)
Circulating and Brain Lipidomics, Cognition and Dementia$754,765
R01 · FY2025 · AG
Core D: Neuropathology Core$462,980
P30 · FY2025 · AG · contact PI
Circulating and Brain Lipidomics, Cognition and Dementia$790,242
R01 · FY2024 · AG
Core D: Neuropathology Core$541,511
P30 · FY2024 · AG · contact PI
Core D: Neuropathology Core$567,987
P30 · FY2023 · AG · contact PI
Core G Neuropath$373,301
U19 · FY2023 · AG · contact PI
Core D: Neuropathology Core$593,723
P30 · FY2022 · AG · contact PI
Core G Neuropath$373,301
U19 · FY2022 · AG · contact PI
Core D: Neuropathology Core$596,366
P30 · FY2021 · AG · contact PI
Core G Neuropath$571,271
U19 · FY2021 · AG · contact PI
Core D: Neuropathology Core$466,224
P30 · FY2020 · AG · contact PI
Core G Neuropath$75,679
U19 · FY2020 · AG · contact PI
Core D: Neuropathology Core$236,907
P50 · FY2019 · AG · contact PI
Core G Neuropath$185,572
U19 · FY2019 · AG · contact PI
Neuropathology Core$41,574
P50 · FY2019 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,619,042
U01 · FY2018 · AG
ALZHEIMER'S DISEASE BEFORE PLAQUES AND TANGLES: Abeta-AMYLOID OLIGOMERS AND THE GLYMPHATIC PATHWAY$245,532
R21 · FY2018 · AG · contact PI
Core D: Neuropathology Core$237,230
P50 · FY2018 · AG · contact PI
Neuropath Core$233,888
P50 · FY2018 · NS · contact PI
Core G: Neuropathology$67,170
U19 · FY2018 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,631,705
U01 · FY2017 · AG
Core D: Neuropathology Core$237,040
P50 · FY2017 · AG · contact PI
Neuropath Core$233,888
P50 · FY2017 · NS · contact PI
ALZHEIMER'S DISEASE BEFORE PLAQUES AND TANGLES: Abeta-AMYLOID OLIGOMERS AND THE GLYMPHATIC PATHWAY$204,375
R21 · FY2017 · AG · contact PI
Discovery of Novel Proteomic Targets in Alzheimer's Disease$156,000
U01 · FY2017 · AG
Research Education Program in Experimental Neuropathology$76,400
R25 · FY2017 · NS · contact PI
Core G: Neuropathology$67,174
U19 · FY2017 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,541,709
U01 · FY2016 · AG
Core D: Neuropathology Core$251,369
P50 · FY2016 · AG · contact PI
Neuropath Core$233,888
P50 · FY2016 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$160,872
U01 · FY2016 · AG
Research Education Program in Experimental Neuropathology$76,400
R25 · FY2016 · NS · contact PI
Core G: Neuropathology$67,172
U19 · FY2016 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,516,903
U01 · FY2015 · AG
Core D: Neuropathology Core$236,907
P50 · FY2015 · AG · contact PI
Neuropath Core$233,887
P50 · FY2015 · NS · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$132,600
U01 · FY2015 · AG
Research Education Program in Experimental Neuropathology$87,774
R25 · FY2015 · NS · contact PI
Core G: Neuropathology$65,154
U19 · FY2015 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$1,530,583
U01 · FY2014 · AG
Neuropath Core$283,500
P50 · FY2014 · NS · contact PI
NEUROPATHOLOGY CORE$216,470
P50 · FY2014 · AG · contact PI
Discovery of Novel Proteomic Targets for Treatment of Alzheimer's Disease$110,684
U01 · FY2014 · AG
Research Education Program in Experimental Neuropathology$70,401
R25 · FY2014 · NS · contact PI
Core G: Neuropathology$67,173
U19 · FY2014 · AG · contact PI
Research Education Program in Experimental Neuropathology$1
R25 · FY2014 · NS · contact PI
NEUROPATHOLOGY CORE$210,684
P50 · FY2013 · AG · contact PI
Research Education Program in Experimental Neuropathology$1,620
R25 · FY2013 · NS · contact PI
Research Education Program in Experimental Neuropathology$1
R25 · FY2013 · NS · contact PI
NEUROPATHOLOGY CORE$237,428
P50 · FY2012 · AG · contact PI
Research Education Program in Experimental Neuropathology$51,720
R25 · FY2012 · NS · contact PI
NEUROPATHOLOGY CORE$243,434
P50 · FY2011 · AG · contact PI
NEUROPATHOLOGY CORE$219,985
P50 · FY2010 · AG · contact PI
nueropathy core$112,146
P50 · FY2010 · NS · contact PI
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD$273,490
P50 · FY2009 · AG · contact PI
NEUROPATHOLOGY CORE$232,696
P50 · FY2009 · AG · contact PI
nueropathy core$105,674
P50 · FY2009 · NS · contact PI
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD$259,037
P50 · FY2008 · AG · contact PI
Neuropathology Core$256,459
P50 · FY2008 · NS · contact PI
NEUROPATHOLOGY CORE$221,063
P50 · FY2008 · AG · contact PI
nueropathy core$105,660
P50 · FY2008 · NS · contact PI
Neuropathology Core$256,318
P50 · FY2007 · NS · contact PI
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD$240,207
P50 · FY2007 · AG · contact PI
NEUROPATHOLOGY CORE$205,026
P50 · FY2007 · AG · contact PI
nueropathy core$119,687
P01 · FY2007 · NS · contact PI
Neuropathology Core$226,148
P50 · FY2006 · NS · contact PI
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD$128,749
P50 · FY2006 · AG · contact PI
NEUROPATHOLOGY CORE$121,701
P50 · FY2006 · AG · contact PI
nueropathy core$105,567
P01 · FY2006 · NS · contact PI
Neuropathology Core$219,561
P50 · FY2005 · NS
NEUROPATHOLOGY AND MECHANISMS IN PRECLINICAL AD$125,000
P50 · FY2005 · AG
NEUROPATHOLOGY CORE$106,689
P50 · FY2005 · AG
Neuropathology Core$213,165
P50 · FY2004 · NS
Core--Neuropathology$158,272
P50 · FY2002 · AG
Inflammatory cells and mediators in early stages of Alzhiemer's disease$158,272
P50 · FY2002 · AG
COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE--ROLE OF ALPHA-SYNUCLEIN$88,647
P50 · FY2002 · NS
CORE--NEUROPATHOLOGY$88,647
P50 · FY2002 · NS
CORE--NEUROPATHOLOGY$172,411
P01 · FY2001 · NS
Core--Neuropathology$158,272
P50 · FY2001 · AG
Inflammatory cells and mediators in early stages of Alzhiemer's disease$158,272
P50 · FY2001 · AG
CORE--NEUROPATHOLOGY$88,647
P50 · FY2001 · NS
COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE--ROLE OF ALPHA-SYNUCLEIN$88,647
P50 · FY2001 · NS
CORE--NEUROPATHOLOGY$0
P50 · FY2001 · NS
COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE--ROLE OF ALPHA-SYNUCLEIN$0
P50 · FY2001 · NS
Core--Neuropathology$247,780
P50 · FY2000 · AG
Inflammatory cells and mediators in early stages of Alzhiemer's disease$247,777
P50 · FY2000 · AG
CORE--NEUROPATHOLOGY$229,310
P50 · FY2000 · NS
COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE--ROLE OF ALPHA-SYNUCLEIN$229,310
P50 · FY2000 · NS